ethosuximide sold brand name zarontin among others medication used treat absence may used antiseizure medications valproic ethosuximide taken ethosuximide usually well common side effects include loss appetite abdominal pain diarrhea feeling serious side effects include suicidal thoughts low blood cell levels lupus unclear adverse effects fetus ethosuximide succinimide family medications mechanism action thought due antagonism postsynaptic ttype voltagegated calcium ethosuximide approved medical use united states world health organizations list essential ethosuximide available generic availability limited many countries concerns price fixing united approved absence ethosuximide considered first choice drug treating absence seizures part lacks idiosyncratic hepatotoxicity alternative antiabsence drug valproic anticonvulsants ethosuximide carries warning use pregnancy although causal relationship birth defects established potential harm baby weighed known harm caused mother even minor following occur without bone marrow loss valproates either decrease increase levels ethosuximide however combinations valproates ethosuximide greater protective index either drug may elevate serum phenytoin levels mechanism ethosuximide affects neuronal excitability includes block ttype calcium channels may include effects drug classes ion channel primary finding ethosuximide ttype calcium channel blocker gained widespread support initial attempts replicate finding inconsistent subsequent experiments recombinant ttype channels cell lines demonstrated conclusively ethosuximide blocks ttype calcium channel isoformscitation needed significant ttype calcium channel density occurs dendrites neurons recordings reduced preparations strip away dendritic source ttype calcium channels may contributed reports ethosuximide ineffectiveness march coulter huguenard prince showed ethosuximide dimethadione effective antiabsence agents reduced lowthreshold currents ttype calcium channels freshly removed thalamic june year also found mechanism reduction voltagedependent using acutely dissociated neurons rats guinea pigs also noted valproic acid also used absence seizures next year showed anticonvulsant succinimides proconvulsant ones first part supported kostyuk et al reported substantial reduction current dorsal root ganglia concentrations ranging Î¼moll year however herrington lingle found effect concentrations year study conducted human neocortical cells removed surgery intractable epilepsy first use human tissue found ethosuximide effect currents concentrations typically needed therapeutic slobodan todorovic christopher j lingle washington university reported block ttype current dorsal root ganglia mmoll far higher kostyuk year leresche et al reported ethosuximide effect ttype currents decrease noninactivating na current k currents rat cat thalamocortical cells concluded decrease na current responsible antiabsence introduction paper published dr juan carlos gomora colleagues university virginia charlottesville pointed past studies often done isolated neurons lost ttype using cloned ttype calcium channels gomoras team found ethosuximide blocked channels mmoll ndesmethylmethsuximide active metabolite mesuximide mmoll mmoll mmoll suggested blockade open channels facilitated ethosuximides physically plugging channels current flows inward ethosuximide chiral drug stereocenter therapeutically racemate mixture r isomers concerns united states price ethosuximide inflated availability ethosuximide limited many marketed trade names emeside zarontin however capsule preparations discontinued production leaving generic preparations available emeside capsules discontinued manufacturer laboratories applied biology similarly zarontin capsules discontinued pfizer syrup preparations brands remained available httpsenwikipediaorgwikiethosuximide